AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 18 filers reported holding AEROVATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,271,540 | -20.9% | 756,930 | 0.0% | 0.22% | -7.2% |
Q2 2023 | $12,981,350 | -15.0% | 756,930 | 0.0% | 0.24% | -21.7% |
Q1 2023 | $15,267,278 | -31.4% | 756,930 | -0.3% | 0.30% | -29.6% |
Q4 2022 | $22,254,522 | +68.8% | 759,540 | -4.5% | 0.43% | +73.9% |
Q3 2022 | $13,181,000 | +76.2% | 795,000 | +66.1% | 0.24% | +80.1% |
Q2 2022 | $7,480,000 | -20.0% | 478,579 | -6.2% | 0.14% | -10.5% |
Q1 2022 | $9,347,000 | +48.0% | 509,949 | -4.8% | 0.15% | +87.7% |
Q4 2021 | $6,316,000 | -43.8% | 535,714 | 0.0% | 0.08% | -34.7% |
Q3 2021 | $11,239,000 | -8.1% | 535,714 | 0.0% | 0.12% | 0.0% |
Q2 2021 | $12,230,000 | – | 535,714 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 603,762 | $17,690,227 | 28.88% |
Atlas Venture Life Science Advisors, LLC | 2,017,521 | $59,113,365 | 7.12% |
Sofinnova Investments, Inc. | 3,758,686 | $110,129,500 | 6.54% |
TCG Crossover Management, LLC | 1,081,274 | $31,681,328 | 5.59% |
RA Capital Management | 8,263,982 | $242,134,673 | 4.91% |
Cormorant Asset Management, LP | 1,957,132 | $57,344 | 3.84% |
VR Adviser, LLC | 747,869 | $21,912,562 | 3.69% |
Octagon Capital Advisors LP | 621,712 | $18,216,162 | 2.84% |
GREAT POINT PARTNERS LLC | 378,522 | $11,090,695 | 2.17% |
Ghost Tree Capital, LLC | 135,000 | $3,956,000 | 1.69% |